THC
Price
$270.73
Change
+$1.60 (+0.59%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
21.67B
7 days until earnings call
Intraday BUY SELL Signals
USPH
Price
$88.86
Change
+$2.58 (+2.99%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
1.29B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

THC vs USPH

THC vs USPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
THC vs. USPH commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is THC is a Buy and USPH is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for THC with price predictions
Oct 22, 2026

Momentum Indicator for THC turns positive, indicating new upward trend

THC saw its Momentum Indicator move above the 0 level on October 07, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned positive. In 67 of the 77 cases, the stock moved higher in the following days. The odds of a move higher are at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for THC just turned positive on October 09, 2026. Looking at past instances where THC's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.

THC moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for THC crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where THC advanced for three days, in 266 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The 10-day RSI Indicator for THC moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 56 similar instances where the indicator moved out of overbought territory. In 36 of the 56 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 61 cases where THC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 59%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

THC broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for THC entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 15 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. THC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.652) is normal, around the industry mean (204.132). P/E Ratio (10.327) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (1.789) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (1.022) is also within normal values, averaging (2.688).

A.I.Advisor
a Summary for USPH with price predictions
Oct 22, 2026

USPH in downward trend: price may drop because broke its higher Bollinger Band on October 22, 2026

USPH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In 26 of the 35 cases the stock fell afterwards. This puts the odds of success at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for USPH moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 27 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where USPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on USPH as a result. In 55 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for USPH just turned positive on October 22, 2026. Looking at past instances where USPH's MACD turned positive, the stock continued to rise in 28 of 42 cases over the following month. The odds of a continued upward trend are 67%.

Following a +2.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where USPH advanced for three days, in 217 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

The Aroon Indicator entered an Uptrend today. In 159 of 254 cases where USPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. USPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.870) is normal, around the industry mean (204.132). USPH's P/E Ratio (507.529) is considerably higher than the industry average of (18.957). Projected Growth (PEG Ratio) (2.823) is also within normal values, averaging (2.498). Dividend Yield (0.021) settles around the average of (0.100) among similar stocks. P/S Ratio (1.556) is also within normal values, averaging (2.688).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

FUNDAMENTALS RATINGS
THC vs USPH: Fundamental Ratings
THC
USPH
OUTLOOK RATING
1..100
2589
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
15100
SMR RATING
1..100
2090
PRICE GROWTH RATING
1..100
3742
P/E GROWTH RATING
1..100
641
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

THC's Valuation (74) in the Hospital Or Nursing Management industry is in the same range as USPH (97) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to USPH’s over the last 12 months.

THC's Profit vs Risk Rating (15) in the Hospital Or Nursing Management industry is significantly better than the same rating for USPH (100) in the Medical Or Nursing Services industry. This means that THC’s stock grew significantly faster than USPH’s over the last 12 months.

THC's SMR Rating (20) in the Hospital Or Nursing Management industry is significantly better than the same rating for USPH (90) in the Medical Or Nursing Services industry. This means that THC’s stock grew significantly faster than USPH’s over the last 12 months.

THC's Price Growth Rating (37) in the Hospital Or Nursing Management industry is in the same range as USPH (42) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to USPH’s over the last 12 months.

USPH's P/E Growth Rating (1) in the Medical Or Nursing Services industry is somewhat better than the same rating for THC (64) in the Hospital Or Nursing Management industry. This means that USPH’s stock grew somewhat faster than THC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
THCUSPH
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 11 days ago
66%
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
63%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (THC: $270.63 vs. USPH: $88.73)
Brand notoriety: THC and USPH are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: THC: 84% vs. USPH: 76%
Market capitalization -- THC: $21.67B vs. USPH: $1.29B
THC [@Hospital/Nursing Management] is valued at $21.67B. USPH’s [@Hospital/Nursing Management] market capitalization is $1.29B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $99.46B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

THC’s FA Score shows that 2 FA rating(s) are green while USPH’s FA Score has 1 green FA rating(s).

  • THC’s FA Score: 2 green, 3 red.
  • USPH’s FA Score: 1 green, 4 red.
According to our system of comparison, THC is a better buy in the long-term than USPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

THC’s TA Score shows that 5 TA indicator(s) are bullish while USPH’s TA Score has 4 bullish TA indicator(s).

  • THC’s TA Score: 5 bullish, 5 bearish.
  • USPH’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, USPH is a better buy in the short-term than THC.

Price Growth

THC (@Hospital/Nursing Management) experienced а -1.64% price change this week, while USPH (@Hospital/Nursing Management) price change was +3.20% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.24%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was +22.44%.

Reported Earning Dates

THC is expected to report earnings on Oct 29, 2026.

USPH is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+1.24% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
THC
Daily Signal:
Gain/Loss:
USPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

USPH and

Correlation & Price change

A.I.dvisor tells us that USPH and BTMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that USPH and BTMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USPH
1D Price
Change %
USPH100%
+2.84%
BTMD - USPH
30%
Poorly correlated
+5.83%
OPCH - USPH
29%
Poorly correlated
N/A
ENSG - USPH
29%
Poorly correlated
+2.88%
THC - USPH
27%
Poorly correlated
+0.56%
INNV - USPH
25%
Poorly correlated
+4.16%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBOT2.850.17
+6.34%
BridgeBio Oncology Therapeutics Inc
CIGI96.463.71
+4.00%
Colliers International Group
MMI28.280.14
+0.50%
Marcus & Millichap
PCAR109.59-0.63
-0.57%
PACCAR
KYNB5.04-0.17
-3.26%
Kyntra Bio Inc